Cargando…
Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics
BACKGROUND: Abnormal Savda Munziq (ASMq) is a traditional Uyghur herbal preparation used as a therapy for abnormal Savda-related diseases. In this study, we investigate ASMq's dynamic effects on abnormal Savda rat models under different disease conditions. MATERIALS AND METHODS: Abnormal Savda...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621637/ https://www.ncbi.nlm.nih.gov/pubmed/26600713 http://dx.doi.org/10.4103/0973-1296.165551 |
_version_ | 1782397467629715456 |
---|---|
author | Mamtimin, Batur Xia, Guo Mijit, Mahmut Hizbulla, Mawlanjan Kurbantay, Nazuk You, Li Upur, Halmurat |
author_facet | Mamtimin, Batur Xia, Guo Mijit, Mahmut Hizbulla, Mawlanjan Kurbantay, Nazuk You, Li Upur, Halmurat |
author_sort | Mamtimin, Batur |
collection | PubMed |
description | BACKGROUND: Abnormal Savda Munziq (ASMq) is a traditional Uyghur herbal preparation used as a therapy for abnormal Savda-related diseases. In this study, we investigate ASMq's dynamic effects on abnormal Savda rat models under different disease conditions. MATERIALS AND METHODS: Abnormal Savda rat models with hepatocellular carcinoma (HCC), type 2 diabetes mellitus (T2DM), and asthma dosed of ASMq. Serum samples of each animal tested by nuclear magnetic resonance spectroscopy and analyzed by orthogonal projection to latent structure with discriminant analysis. RESULTS: Compared with healthy controls, HCC rats had higher concentrations of amino acids, fat-related metabolites, lactate, myoinositol, and citrate, but lower concentrations of α-glucose, β-glucose, and glutamine. Following ASMq treatment, the serum acetone very low-density lipoprotein (VLDL), LDL, unsaturated lipids, acetylcysteine, and pyruvate concentration decreased, but α-glucose, β-glucose, and glutamine concentration increased (P < 0.05). T2DM rats had higher concentrations of α- and β-glucose, but lower concentrations of isoleucine, leucine, valine, glutamine, glycoprotein, lactate, tyrosine, creatine, alanine, carnitine, and phenylalanine. After ASMq treated T2DM groups showed reduced α- and β-glucose and increased creatine levels (P < 0.05). Asthma rats had higher acetate, carnitine, formate, and phenylalanine levels, but lower concentrations of glutamine, glycoprotein, lactate, VLDL, LDL, and unsaturated lipids. ASMq treatment showed increased glutamine and reduced carnitine, glycoprotein, formate, and phenylalanine levels (P < 0.05). CONCLUSION: Low immune function, decreased oxidative defense, liver function abnormalities, amino acid deficiencies, and energy metabolism disorders are common characteristics of abnormal Savda-related diseases. ASMq may improve the abnormal metabolism and immune function of rat models with different diseases combined abnormal Savda. |
format | Online Article Text |
id | pubmed-4621637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46216372015-11-23 Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics Mamtimin, Batur Xia, Guo Mijit, Mahmut Hizbulla, Mawlanjan Kurbantay, Nazuk You, Li Upur, Halmurat Pharmacogn Mag Original Article BACKGROUND: Abnormal Savda Munziq (ASMq) is a traditional Uyghur herbal preparation used as a therapy for abnormal Savda-related diseases. In this study, we investigate ASMq's dynamic effects on abnormal Savda rat models under different disease conditions. MATERIALS AND METHODS: Abnormal Savda rat models with hepatocellular carcinoma (HCC), type 2 diabetes mellitus (T2DM), and asthma dosed of ASMq. Serum samples of each animal tested by nuclear magnetic resonance spectroscopy and analyzed by orthogonal projection to latent structure with discriminant analysis. RESULTS: Compared with healthy controls, HCC rats had higher concentrations of amino acids, fat-related metabolites, lactate, myoinositol, and citrate, but lower concentrations of α-glucose, β-glucose, and glutamine. Following ASMq treatment, the serum acetone very low-density lipoprotein (VLDL), LDL, unsaturated lipids, acetylcysteine, and pyruvate concentration decreased, but α-glucose, β-glucose, and glutamine concentration increased (P < 0.05). T2DM rats had higher concentrations of α- and β-glucose, but lower concentrations of isoleucine, leucine, valine, glutamine, glycoprotein, lactate, tyrosine, creatine, alanine, carnitine, and phenylalanine. After ASMq treated T2DM groups showed reduced α- and β-glucose and increased creatine levels (P < 0.05). Asthma rats had higher acetate, carnitine, formate, and phenylalanine levels, but lower concentrations of glutamine, glycoprotein, lactate, VLDL, LDL, and unsaturated lipids. ASMq treatment showed increased glutamine and reduced carnitine, glycoprotein, formate, and phenylalanine levels (P < 0.05). CONCLUSION: Low immune function, decreased oxidative defense, liver function abnormalities, amino acid deficiencies, and energy metabolism disorders are common characteristics of abnormal Savda-related diseases. ASMq may improve the abnormal metabolism and immune function of rat models with different diseases combined abnormal Savda. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4621637/ /pubmed/26600713 http://dx.doi.org/10.4103/0973-1296.165551 Text en Copyright: © Pharmacognosy Magazine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Mamtimin, Batur Xia, Guo Mijit, Mahmut Hizbulla, Mawlanjan Kurbantay, Nazuk You, Li Upur, Halmurat Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics |
title | Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics |
title_full | Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics |
title_fullStr | Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics |
title_full_unstemmed | Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics |
title_short | Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics |
title_sort | metabolic differentiation and classification of abnormal savda munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621637/ https://www.ncbi.nlm.nih.gov/pubmed/26600713 http://dx.doi.org/10.4103/0973-1296.165551 |
work_keys_str_mv | AT mamtiminbatur metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics AT xiaguo metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics AT mijitmahmut metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics AT hizbullamawlanjan metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics AT kurbantaynazuk metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics AT youli metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics AT upurhalmurat metabolicdifferentiationandclassificationofabnormalsavdamunziqspharmacodynamicroleonratmodelswithdifferentdiseasesbynuclearmagneticresonancebasedmetabonomics |